---
title: "Bottoming out and rebounding! AKESO surged 5%, and Hwabao WP Hang Seng SCHK Innovative Drug ETF (520880) rose 1.58%! Funds have increased positions for 7 consecutive days"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287141424.md"
description: "As of May 21, 2026, the Hwabao (520880) Hang Seng SCHK Innovative Drug ETF rose by 1.81%, with the latest price reported at 0.450 yuan. Funds have been continuously increased for 7 days, with a total of 392 million yuan raised in the past week. This ETF closely tracks the Hang Seng SCHK Innovative Drug Select Index, with the latest scale reaching 2.665 billion yuan and a total of 5.982 billion shares"
datetime: "2026-05-21T01:41:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287141424.md)
  - [en](https://longbridge.com/en/news/287141424.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287141424.md)
---

# Bottoming out and rebounding! AKESO surged 5%, and Hwabao WP Hang Seng SCHK Innovative Drug ETF (520880) rose 1.58%! Funds have increased positions for 7 consecutive days

As of May 21, 2026, 09:39, the Hong Kong Stock Connect Innovative Drug ETF Hwabao (520880) rose by 1.81%, with the latest price reported at 0.450 yuan and a turnover rate of 2.29%.

The Hong Kong Stock Connect Innovative Drug ETF Hwabao (520880) closely tracks the Hang Seng Stock Connect Innovative Drug Select Index. Among the index-weighted stocks, Zai Lab rose by 3.07%, AKESO rose by 2.61%, and BeiGene rose by 2.04%, while Rongchang Bio fell by 2.95% and Kelun Biotech fell by 1.3%. The index aims to reflect the performance of Hong Kong-listed companies that can be traded through the Stock Connect and are engaged in the research, development, and production of innovative drugs. Base date: December 31, 2020. Base point: 3000.

Data shows that the latest size of the Hong Kong Stock Connect Innovative Drug ETF Hwabao (520880) has reached 2.665 billion yuan, with the latest shares totaling 5.982 billion, an increase of 423 million yuan in fund size compared to a month ago.

As of the previous trading day, the Hong Kong Stock Connect Innovative Drug ETF Hwabao (520880) received a net inflow of 40.747 million yuan, accumulating 392 million yuan in the past week.

Hong Kong Stock Connect Innovative Drug ETF Hwabao (520880), off-exchange connection (025220.OF, 025221.OF)

### Related Stocks

- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [ZLAB.US](https://longbridge.com/en/quote/ZLAB.US.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)
- [688331.CN](https://longbridge.com/en/quote/688331.CN.md)
- [06990.HK](https://longbridge.com/en/quote/06990.HK.md)

## Related News & Research

- [Universal Digital Inc. Announces Termination of ETF Partnership Agreement | LFGMF Stock News](https://longbridge.com/en/news/286616540.md)
- [1 Rapidly Deteriorating ETF Screams That ‘Shop ‘Til You Drop’ Americans Have All But Keeled Over](https://longbridge.com/en/news/286429552.md)
- [VanEck, Grayscale file fresh BNB ETF amendments as race for next altcoin spot ETF accelerates](https://longbridge.com/en/news/286652991.md)
- [Worried About a Market Crash? 3 Vanguard ETFs Built to Survive](https://longbridge.com/en/news/286880525.md)
- [$100 Invested In iShares S&P 500 Growth ETF 20 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/286800978.md)